Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 2, Issue 1
January 9 2018
Issue Cover

Table of Contents

STIMULUS REPORTS

Successful treatment with fingolimod of graft-versus-host disease of the central nervous system
Clinical Trials & Observations
Jordan Gauthier,Patrick Vermersch,Paul Chauvet,Pauline Varlet,Valérie Coiteux,Leonardo Magro,Ibrahim Yakoub-Agha
View Articletitled, Successful treatment with fingolimod of graft-versus-host disease of the central nervous system
Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells
Russell G. Witt,Emily M. Kreger,Laura B. Buckman,Patriss W. Moradi,Phong T. Ho,S. Christopher Derderian,Perry Tsai,Chris Baker,Nathaniel Schramm,Rachel Cleary,J. Victor Garcia,Tippi C. MacKenzie
View Articletitled, Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms
Judith C. W. Marsh,Fernanda Gutierrez-Rodrigues,James Cooper,Jie Jiang,Shreyans Gandhi,Sachiko Kajigaya,Xingmin Feng,Maria del Pilar F. Ibanez,Flávia S. Donaires,João P. Lopes da Silva,Zejuan Li,Soma Das,Maria Ibanez,Alexander E. Smith,Nicholas Lea,Steven Best,Robin Ireland,Austin G. Kulasekararaj,Donal P. McLornan,Anthony Pagliuca,Isabelle Callebaut,Neal S. Young,Rodrigo T. Calado,Danielle M. Townsley,Ghulam J Mufti
View Articletitled, Heterozygous <em>RTEL1</em> variants in bone marrow failure and myeloid neoplasms
Supplemental data
Hereditary folate malabsorption due to a mutation in the external gate of the proton-coupled folate transporter SLC46A1
Srinivas Aluri,Rongbao Zhao,Charlotte Lubout,Susanna M. I. Goorden,Andras Fiser,I. David Goldman
View Articletitled, Hereditary folate malabsorption due to a mutation in the external gate of the proton-coupled folate transporter SLC46A1

LYMPHOID NEOPLASIA

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
Clinical Trials & Observations
Maximilian Merz,Anna Jauch,Thomas Hielscher,Tilmann Bochtler,Stefan Olaf Schönland,Anja Seckinger,Dirk Hose,Uta Bertsch,Kai Neben,Marc Steffen Raab,Jens Hillengass,Hans Salwender,Igor Wolfgang Blau,Hans-Walter Lindemann,Ingo G. H. Schmidt-Wolf,Christof Scheid,Mathias Haenel,Katja C. Weisel,Hartmut Goldschmidt
View Articletitled, Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging
T. R. L. Klei,D. Z. de Back,P. J. Asif,P. J. J. H. Verkuijlen,M. Veldthuis,P. C. Ligthart,J. Berghuis,E. Clifford,B. M. Beuger,T. K. van den Berg,R. van Zwieten,W. El Nemer,R. van Bruggen
View Articletitled, Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging
Supplemental data

THROMBOSIS AND HEMOSTASIS

Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice
Sravya Kattula,James R. Byrnes,Sara M. Martin,Lori A. Holle,Brian C. Cooley,Matthew J. Flick,Alisa S. Wolberg
View Articletitled, Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice
Supplemental data

TRANSPLANTATION

Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies
Clinical Trials & Observations
Brigitte T. A. van den Broek,Kristin Page,Annalisa Paviglianiti,Janna Hol,Heather Allewelt,Fernanda Volt,Gerard Michel,Miguel Angel Diaz,Victoria Bordon,Tracey O'Brien,Peter J. Shaw,Chantal Kenzey,Amal Al-Seraihy,Peter M. van Hasselt,Andrew R. Gennery,Eliane Gluckman,Vanderson Rocha,Annalisa Ruggeri,Joanne Kurtzberg,Jaap Jan Boelens,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center,on behalf of Eurocord, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation, and Duke University Medical Center
View Articletitled, Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies
Supplemental data

ERRATUM

Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347.
View Articletitled, Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. <em>Blood Adv.</em> 2017;1(25):2343-2347.
  • Cover Image

    Cover Image

    issue cover

    COVER FIGURE
    Homology models of the proton-coupled folate transporter in the inward-open (blue) and outward-open (green) conformations. The 11th transmembrane domain and the Asn411 residue are highlighted. This residue is located within the external gate of the protein protruding into the aqueous channel and shifts further into the channel when the protein is in the inward-open conformation and the gate is closed. Mutation of Asn411 to Lys411 markedly impaired transport function, resulting in the autosomal recessive disorder hereditary folate malabsorption. See the article by Aluri et al.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement intended for health care professionals

American Society of Hematology: Building a Comprehensive Minority Recruitment and Retention Professional Program
A contemporary downtrend in chronic GVHD?
Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.
Glisovic-Aplenc T, Diorio C, Chukinas JA, et al. CD38 as a pan-hematologic target for chimeric antigen receptor T cells. Blood Adv. 2023;7(16):4418-4430.
Sewastianik T, Jiang M, Sukhdeo K, et al. Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice. Blood Adv. 2017;1(25):2361-2374.

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals